Difference between revisions of "De Jesus-Acosta A, et al. Invest. N. Drugs (2014) cited as Ref 586 in DOI: 10.1038/s41392-020-0110-5 (Q9849)"
Jump to navigation
Jump to search
(Added link to [sliswiki]: De Jesus-Acosta A, et al. Invest. N. Drugs (2014) cited as Ref 586 in DOI: 10.1038/s41392-020-0110-5, #quickstatements; #temporary_batch_1589988087154) |
(Created claim: First Author string (P149): De Jesus-Acosta A, #quickstatements; #temporary_batch_1589996169159) |
||
| Property / First Author string | |||
| + | De Jesus-Acosta A | ||
| Property / First Author string: De Jesus-Acosta A / rank | |||
| + | Normal rank | ||
Revision as of 17:55, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
De Jesus-Acosta A, et al. Invest. N. Drugs (2014) cited as Ref 586 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
De Jesus-Acosta A
0 references
